Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Long-term survival data for Rencarex in metastatic renal cell carcinoma

March 5, 2004

New round of financing at Igeneon to advance lead candidates

March 4, 2004

Advanced Viral Research reports in vitro biologic effects of AVR-118

March 3, 2004

Promising results found for an autologous melanoma cancer vaccine

March 2, 2004

SGN-30 receives orphan drug designation for T-cell lymphomas

March 1, 2004

Micromet and Boehringer Ingelheim collaborate on MT-201 manufacturing

Feb. 27, 2004

Seattle Genetics and Abbott sign manufacturing agreement for SGN-30

Feb. 26, 2004

Enrollment scheduled to conclude in pivotal MyVax trial

Feb. 23, 2004

Harvard Group to acquire assets of NexTherapeutics; IND anticipated for NXT-211

Feb. 20, 2004

New phase II study for MT-201 in prostate cancer

Feb. 16, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...